2005
DOI: 10.1002/sim.1973
|View full text |Cite
|
Sign up to set email alerts
|

Concomitant information in bioassay and semi-parametric estimation

Abstract: This paper presents a flexible modern approach to handling concomitant information for estimating the relative potency parameter in quantitative bioassays. This is accomplished in a semi-parametric framework where the concomitant variable is included non-parametrically. Estimation is then performed using smoothing splines where the point and interval estimators of the relative potency parameter exhibits desirable asymptotic properties.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2006
2006
2006
2006

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…Dose escalation with overdose control was proposed in cancer phase I trials [426]. Concomitant information in bioassay can be incorporated in a semi-parametric model [427]. Dose-finding designs accounted for two endpoints using utilities [428,429] and Bayesian designs for dose-escalation studies in healthy volunteers were compared [430].…”
Section: Clinical Trialsmentioning
confidence: 99%
“…Dose escalation with overdose control was proposed in cancer phase I trials [426]. Concomitant information in bioassay can be incorporated in a semi-parametric model [427]. Dose-finding designs accounted for two endpoints using utilities [428,429] and Bayesian designs for dose-escalation studies in healthy volunteers were compared [430].…”
Section: Clinical Trialsmentioning
confidence: 99%